168 related articles for article (PubMed ID: 20558354)
1. [Macroprolactinemia associated with pituitary macroadenoma: treatment with quinagolide].
Lakatos G; Szücs N; Kender Z; Czirják S; Rácz K
Orv Hetil; 2010 Jun; 151(26):1072-5. PubMed ID: 20558354
[TBL] [Abstract][Full Text] [Related]
2. Importance of macroprolactinemia in hyperprolactinemia.
Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
[TBL] [Abstract][Full Text] [Related]
3. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
Lu CC; Hsieh CJ
Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
[TBL] [Abstract][Full Text] [Related]
4. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
Ferone D; Lastoria S; Colao A; Varrella P; Cerbone G; Acampa W; Merola B; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1998 Jan; 83(1):248-52. PubMed ID: 9435450
[TBL] [Abstract][Full Text] [Related]
5. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
6. Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance.
Elenkova A; Genov N; Abadzhieva Z; Kirilov G; Vasilev V; Kalinov K; Zacharieva S
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):201-5. PubMed ID: 23595795
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of hyperprolactinemic anovulation with the dopamin-agonist quinagolide].
Koloszár S; Keresztúri A; Kovács L
Orv Hetil; 2000 Jul; 141(29):1621-3. PubMed ID: 10962898
[TBL] [Abstract][Full Text] [Related]
8. The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis.
Broekhof R; Gosselink MJ; Pijl H; Giltay EJ
Gen Hosp Psychiatry; 2012; 34(2):209.e1-3. PubMed ID: 21872335
[TBL] [Abstract][Full Text] [Related]
9. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
[TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and reproductive manifestations of macroprolactinemia.
Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of quinagolide in resistance to dopamine agonists: results of a multicenter study. Club de l'Hypophyse.
Rohmer V; Freneau E; Morange I; Simonetta C
Ann Endocrinol (Paris); 2000 Nov; 61(5):411-7. PubMed ID: 11084391
[TBL] [Abstract][Full Text] [Related]
13. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
[TBL] [Abstract][Full Text] [Related]
14. [Some issues in the diagnosis and treatment of hyperprolactinemia].
Jin ZM
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959
[No Abstract] [Full Text] [Related]
15. Frequency of Macroprolactin in Hyperprolactinemia.
Sherazi NA; Baig MZ; Khan AH
J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
[TBL] [Abstract][Full Text] [Related]
16. A Neutral Effect of Metformin Treatment on Macroprolactin Content in Women with Macroprolactinemia.
Krysiak R; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):223-228. PubMed ID: 27750350
[No Abstract] [Full Text] [Related]
17. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
[TBL] [Abstract][Full Text] [Related]
18. [Misleading diagnosis of hyperprolactinemia in women].
Paepegaey AC; Veron L; Wimmer MC; Christin-Maitre S
Gynecol Obstet Fertil; 2016 Mar; 44(3):181-6. PubMed ID: 26966035
[TBL] [Abstract][Full Text] [Related]
19. Macroprolactinemia revisited: a study on 106 patients.
Vallette-Kasic S; Morange-Ramos I; Selim A; Gunz G; Morange S; Enjalbert A; Martin PM; Jaquet P; Brue T
J Clin Endocrinol Metab; 2002 Feb; 87(2):581-8. PubMed ID: 11836289
[TBL] [Abstract][Full Text] [Related]
20. Excessively high prolactin level in a patient with a nonprolactin-secreting adenoma. Case report.
Albuquerque FC; Hinton DR; Weiss MH
J Neurosurg; 1998 Dec; 89(6):1043-6. PubMed ID: 9833836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]